{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:39:51Z","timestamp":1790750391359,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1187,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>The Hedgehog (HH)-signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular\/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate. Therefore, we hypothesized that the level of HH-pathway activation would increase in parallel with the severity of liver damage in NAFLD. To assess potential correlations between known histologic and clinical predictors of advanced liver disease and HH-pathway activation, immunohistochemistry was performed on liver biopsies from a large, well-characterized cohort of NAFLD patients (n = 90) enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 1 study. Increased HH activity (evidenced by accumulation of HH-ligand\u2013producing cells and HH-responsive target cells) strongly correlated with portal inflammation, ballooning, and fibrosis stage (each<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001), supporting a relationship between HH-pathway activation and liver damage. Pathway activity also correlated significantly with markers of liver repair, including numbers of hepatic progenitors and myofibroblastic cells (both<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.03). In addition, various clinical parameters that have been linked to histologically advanced NAFLD, including increased patient age<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.005), body mass index<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.002), waist circumference<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0007), homeostatic model assessment of insulin resistance<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001), and hypertension<\/jats:bold>\n                      (\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.02), correlated with hepatic HH activity.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:bold>In NAFLD patients, the level of hepatic HH-pathway activity is highly correlated with the severity of liver damage and with metabolic syndrome parameters that are known to be predictive of advanced liver disease. Hence, deregulation of the HH-signaling network may contribute to the pathogenesis and sequelae of liver damage that develops with metabolic syndrome.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.25559","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T01:52:04Z","timestamp":1324950724000},"page":"1711-1721","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":194,"title":["Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"55","author":[{"given":"Cynthia D.","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Zdanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal F.","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Unalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20241201","doi-asserted-by":"crossref","first-page":"S99S112","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis.","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"R2-9-20241201","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2007.12.011","article-title":"Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways.","volume":"48","author":"Larter","year":"2008","journal-title":"J Hepatol"},{"key":"R4-9-20241201","doi-asserted-by":"crossref","first-page":"G1093G1106","DOI":"10.1152\/ajpgi.00292.2009","article-title":"Hedgehog pathway activation and epithelialtomesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis.","volume":"297","author":"Choi","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R5-9-20241201","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23019","article-title":"Repairrelated activation of hedgehog signaling promotes cholangiocyte chemokine production.","volume":"50","author":"Omenetti","year":"2009","journal-title":"Hepatology"},{"key":"R6-9-20241201","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histologic associations in adults with nonalcoholic fatty liver disease.","volume":"52","author":"NeuschwanderTetri","year":"2010","journal-title":"Hepatology"},{"key":"R7-9-20241201","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease.","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R8-9-20241201","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.21660","article-title":"Bile ductules and stromal cells express hedgehog ligands andor hedgehog target genes in primary biliary cirrhosis.","volume":"45","author":"Jung","year":"2007","journal-title":"Hepatology"},{"key":"R9-9-20241201","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.","volume":"51","author":"Syn","year":"2010","journal-title":"Hepatology"},{"key":"R10-9-20241201","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/path.2888","article-title":"Increased production of sonic hedgehog by ballooned hepatocytes.","volume":"224","author":"Rangwala","year":"2011","journal-title":"J Pathol"},{"key":"R11-9-20241201","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2010.10.003","article-title":"Hedgehog signaling in the liver.","volume":"54","author":"Omenetti","year":"2011","journal-title":"J Hepatol"},{"key":"R12-9-20241201","doi-asserted-by":"crossref","first-page":"G859G870","DOI":"10.1152\/ajpgi.00456.2005","article-title":"Hedgehog signaling maintains resident hepatic progenitors throughout life.","volume":"290","author":"Sicklick","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R13-9-20241201","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/hep.23649","article-title":"Activation of Rac1 promotes hedgehogmediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells.","volume":"52","author":"Choi","year":"2010","journal-title":"Hepatology"},{"key":"R14-9-20241201","first-page":"3331","article-title":"Hedgehog signaling regulates epithelialmesenchymal transition during biliary fibrosis in rodents and humans.","volume":"118","author":"Omenetti","year":"2008","journal-title":"J Clin Invest"},{"key":"R15-9-20241201","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/hep.23525","article-title":"Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice.","volume":"51","author":"Ochoa","year":"2010","journal-title":"Hepatology"},{"key":"R16-9-20241201","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2009.12.027","article-title":"Drosophila genomewide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate.","volume":"140","author":"Pospisilik","year":"2010","journal-title":"Cell"},{"key":"R17-9-20241201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cmet.2005.11.012","article-title":"Hedgehog signaling plays a conserved role in inhibiting fat formation.","volume":"3","author":"Suh","year":"2006","journal-title":"Cell Metab"},{"key":"R18-9-20241201","doi-asserted-by":"crossref","first-page":"36551","DOI":"10.1074\/jbc.M110.168542","article-title":"Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.","volume":"285","author":"Choi","year":"2010","journal-title":"J Biol Chem"},{"key":"R19-9-20241201","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2007-02-075648","article-title":"The Hedgehog receptor Patched controls lymphoid lineage commitment.","volume":"110","author":"Uhmann","year":"2007","journal-title":"Blood"},{"key":"R20-9-20241201","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.4049\/jimmunol.172.4.2296","article-title":"Reduced thymocyte development in sonic hedgehog knockout embryos.","volume":"172","author":"Shah","year":"2004","journal-title":"J Immunol"},{"key":"R21-9-20241201","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1242\/dev.004432","article-title":"Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4.","volume":"134","author":"Astorga","year":"2007","journal-title":"Development"},{"key":"R23-9-20241201","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1096\/fj.07-8079com","article-title":"Sonic hedgehog carried by microparticles corrects endothelial injury through nitric oxide release.","volume":"21","author":"Agouni","year":"2007","journal-title":"FASEB J"},{"key":"R24-9-20241201","first-page":"75","article-title":"Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases.","volume":"60","author":"Meziani","year":"2008","journal-title":"Pharmacol Rep"},{"key":"R25-9-20241201","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Oerweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-9-20241201","doi-asserted-by":"crossref","first-page":"465343","DOI":"10.1155\/2011\/465343","article-title":"Cancer stem cells: repair gone awry?","volume":"2011","author":"Rangwala","year":"2011","journal-title":"J Oncol"},{"key":"R27-9-20241201","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/carcin\/bgi292","article-title":"Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis.","volume":"27","author":"Sicklick","year":"2006","journal-title":"Carcinogenesis"},{"key":"R28-9-20241201","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weightly connection.","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25559","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:02:10Z","timestamp":1733043730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25559","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}